We have privately discussed management's 10b5 exercise of options and resultant sale of the shares from same. A few other very good investor friends were involved with our communications.
I wasn't happy with the above events, but not unhappy enough to sell a single share. One said it is all about the fundamentals and we are all very pleased and excited about the fundamentals of Antares. My investor friends gave me great comfort that - while it might send a poor message to the uninformed investor - it is really a non-event to anyone who really knows the dynamics of management's option grants and how they play into compensation and rewards for accomplishments. It is not to be given any consideration as involved Buy-Sell- Hold. We are all either holding or buying. During our communications we discussed the probabilities of Otrexup approval and all are extremely optimistic we will be quite happy on October 15th.
I appreciate their help and advice and want to thank them publicly and to assure all others here that if they sufficiently understand the company and the above situation (as I do now) they will be most comfortable[url][/url][tag]insert-text-here[/tag].
" How about "the markets inherent inability to interpret the message correctly."
Management has two choices when they exercise their options. #1. Those options can be converted into shares. #2. They can convert those options into shares & immediately sell them.
Wotten has elected to sell his shares thereby increasing the float & giving a negative impression to the market. I can understand the reasons for reducing his exposure & its difficult to criticize a guy whose moved the company forward. I have less commitment to a company when insiders are selling & I'm sure other feel the same.
News 
Market Data 
Discover 
